In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...
About 43% of patients with sarcoidosis received treatment within 1 year of diagnosis, according to study findings published in Chest. Researchers evaluated treatment rates, treatm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback